Topical Infliximab in Autoimmune Eyes With Keratoprosthesis

Clinical trial NCT02126020 · WITHDRAWN

Trial details

NCT number: NCT02126020
Sponsor: James Chodosh, MD, MPH
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Stevens-Johnson Syndrome Toxic Epidermal Necrolysis (Lyell) Syndrome Mucous Membrane Pemphigoid

Start date: 2014-11-01
Primary completion: 2017-04-03
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.